Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Phaserx Inc (PZRX)

1.01 -0.08 (-7.34%)

10/17/2017  3:59pm

Open:

1.10

Pre. Close:

1.09

High:

1.10

Low:

0.96

Volume:

264,674

Market Cap:

11.81M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-10-17 4:42:04 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.63     One year: 2.21

Support:

Support1: 0.59    Support2: 0.49

Resistance:

Resistance1: 1.39    Resistance2: 1.89

Pivot:

0.90

Moving Averages:

MA(5): 0.97     MA(20): 0.93

MA(100): 0.83     MA(250): 1.20

MACD:

MACD(12,26): 0.06     Signal(12,26,9): 0.05

%K %D:

%K(14,3): 21.71     %D(3): 22.32

RSI:

RSI(14): 59.23

52-Week:

High: 3.30  Low: 0.54  Change(%): -38.8

Average Vol(K):

3-Month: 22565  10-Days 14681

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PZRX has closed below upper band by 13.1%. Bollinger Bands are 18.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 13 Oct 2017 12:56:15 GMT
PhaseRx to cut half its workforce, looks into potential merger

Tue, 17 Oct 2017 14:37:30 GMT
PhaseRx Inc (NASDAQ:PZRX) Is A Prime Takeover Candidate

Mon, 16 Oct 2017 18:11:15 GMT
Drilling Down Into PhaseRx, Inc. (PZRX)

Tue, 17 Oct 2017 09:56:15 GMT
Earnings And Analyst Opinion Offer Spending Insights: PhaseRx, Inc. (PZRX ...

Mon, 25 Sep 2017 18:11:15 GMT
PhaseRx Inc (NASDAQ:PZRX) Is A Hidden Biotech Gem

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

5.08

% Held by Insiders

11.22

% Held by Institutions

51.43

Shares Short (K)

194

Shares Short Prior Month (K)

177

Stock Financials

EPS

-1.240

EPS Est. Current Year

-1.460

EPS Est. Next Year

-1.520

EPS Est. Next Quarter

-0.380

Forward EPS

-1.519

Book Value (p.s.)

0.190

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-54.7

Return on Equity (ttm)

-164.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.159

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.80

Levered Free Cash Flow (M)

-7.45

FoxReading.com

Valuation

P/E

-0.81

P/E Growth Ratio

-0.07

P/BV

5.32

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.